You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The Geisinger National Precision Health Initiative ended in 2019 but its leaders joined Genome Medical to bring genomics-informed care to other health systems.
The center is responsible for developing and maintaining the technical platforms by which people participate in and engage with the program.
The bill would provide additional funding to each NIH institute and center, and would follow a 5.4 percent budget increase received in fiscal 2019.
The All of Us program aims to enroll 1 million Americans willing to donate biological samples and share a variety of genetic and health data.
The program's participant center at the Scripps Research Translational Institute is planning to test different modules for returning results.
The project has signed up about 170,000 participants so far, of whom 100,000 are fully enrolled, and plans to enhance recruitment through pop-up clinics.
The multi-disciplinary health initiative aims to sequence over 100,000 patients' genomes by 2023 as part of its Mosaic Project.
For the two five year grants, the NIH will favor applicants with experience providing counseling throughout the US and to diverse and disadvantaged communities.
The centers will generate genomic data from biosamples contributed by participants in the program and analyze data that will be returned to them.
Fifteen years after the Human Genome Project was declared completed, genomic medicine is beginning to be implemented, sooner than Green and others had expected.
The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.
NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.
Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.
In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.